Akerman is a proud sponsor of the 2026 Cannabis Law Institute, presented by the International Cannabis Bar Association (INCBA). The Cannabis Law Institute is the leading conference dedicated exclusively to cannabis law, and convenes top attorneys, regulators, policymakers, and industry stakeholders to navigate one of the most complex and rapidly evolving legal landscapes in the United States.

Jonathan Robbins, Chair of Akerman’s Cannabis Practice, will speak on a panel titled “After the Reschedule: Navigating the New Federal Cannabis Landscape,” which will examine the DOJ’s historic move to place medical and FDA-approved cannabis in Schedule III. The panelists will discuss the new schedule’s transformative implications and the ongoing legal, regulatory, and operational uncertainties facing the industry as rescheduling unfolds without full federal legalization.